M. Coyle, Christina Mahanty, Siddhartha R. Zunt, Joseph T. Wallin, Mitchell T. Cantey, Paul Clinton White Jr., A. E. O'Neal, Seth A. Serpa, Jose M. Southern, Paul Wilkins, Patricia E. McCarthy, Anne S. Higgs, Elizabeth E. Nash, Theodore Estimated Numbers of Persons Infected with Neurocysticercosis or Epilepsy due to Neurocysticercosis by Region. a<p>See text for methods used to derive these estimates.</p>b<p>Assumes that 10% of those seropositive to <i>T. solium</i> have epilepsy. (Extraction of data from manuscripts summarized in references <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0001500#pntd.0001500-Montano1" target="_blank">[7]</a>, <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0001500#pntd.0001500-Bern1" target="_blank">[11]</a>, <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0001500#pntd.0001500-Flisser1" target="_blank">[31]</a>). Seizure rates in populations seropositive to <i>T. solium</i> were greater than in seronegative populations by approximately 9.4% (range 1.7–31.3%). Therefore, we assumed 10% of seizures were attributable to NCC in Chinese seropositive populations.</p>c<p>Assuming 1/3 of the SSA population of 560 million at risk.</p> numbers;persons;infected;neurocysticercosis;epilepsy 2013-02-20
    https://plos.figshare.com/articles/dataset/_Estimated_Numbers_of_Persons_Infected_with_Neurocysticercosis_or_Epilepsy_due_to_Neurocysticercosis_by_Region_/301066
10.1371/journal.pntd.0001500.t001